Gene Expression in Graves' Ophthalmopathy and Arm Lymphedema: Similarities and Differences
- 1 June 2011
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 21 (6) , 663-674
Abstract
Background: Graves' ophthalmopathy (GO) and lymphedema share some pathogenetic mechanisms, such as edema, inflammation, and adipogenesis. The aim of this study was to examine similarities and differences between chronic GO and chronic lymphedema. Methods: Intraorbital adipose tissue was collected from patients with active (n = 10) or chronic GO (n = 10) and thyroid-healthy controls (n = 10). Arm subcutaneous adipose tissue was obtained from patients with chronic arm lymphedema (n = 10), where the unaffected arm served as a control. Gene expression was studied using microarray and real-time polymerase chain reaction. Results: The following genes were significantly upregulated (p < 0.05) in lymphedema but not in GO and have functions in wound healing, fibrosis, fat metabolism, inflammation, differentiation, development, adhesion, and the cytoskeleton: ATP-binding cassette, sub-family G (WHITE), member 1 (ABCG1), actin, alpha 2, smooth muscle, aorta (ACTA2), secreted frizzled-related protein 2 (SFRP2), tenascin C (TNC), pentraxin-related gene, rapidly induced by IL-1 beta (PTX3), and carboxypeptidase X (M14 family), member 1 (CPMX1). In chronic GO, but not in lymphedema, adipocyte-related immediate early genes known to be overexpressed in patients with active GO were upregulated but at a lower level than previously shown for the active phase. Genes of the Wnt pathway, such as secreted frizzled-related protein 1, 2, and 3, were up- and downregulated in both chronic GO and lymphedema. Parathyroid hormone-like hormone (PTHLH) was downregulated (p = 0.01) and apolipoprotein L domain containing 1 (APOLD1) was upregulated (p = 0.05) in both active and chronic GO. Conclusions: There are more differences than similarities between chronic ophthalmopathy and chronic lymphedema, but both conditions exhibit less inflammation and adipogenesis compared to the active phases. In lymphedema, fibrosis dominates. PTHLH, which can inhibit adipogenesis, is downregulated both in active and chronic ophthalmopathy, indicating the possibility of an increased risk of adipogenesis.Keywords
This publication has 39 references indexed in Scilit:
- Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cellsBone, 2008
- Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated OphthalmopathyThyroid®, 2008
- Mechanisms of FibrogenesisExperimental Biology and Medicine, 2008
- AffyProbeMiner: a web resource for computing or retrieving accurately redefined Affymetrix probe setsBioinformatics, 2007
- Inflammatory Manifestations of Experimental Lymphatic InsufficiencyPLOS Medicine, 2006
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- A new algorithm for analysis of oligonucleotide arrays: application to expression profiling in mouse brain regionsJournal of Molecular Biology, 2002
- Differential Regulation of Immediate Early Gene Expression in Preadipocyte Cells through Multiple Signaling PathwaysBiochemical and Biophysical Research Communications, 1999
- Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissueThe Lancet, 1993
- Is endocrine ophthalmopathy related to smoking?BMJ, 1987